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Abstract
Very few cases of pheochromocytoma in functional accessory adrenal glands have been documented
in literature. We present a twenty-four year old Nigerian female who presented with
pheochromocytoma. Investigations revealed a suprarenal mass, which was diagnosed as an accessory
gland adrenal tumour at surgery. This shows that accessory adrenal glands can be a basis for
development of pheochromocytoma.
Introduction
Pheochromocytomas are catecholamine producing
tumours of the chromaffin cells of the adrenal medulla.
Similar catecholamine producing tumoursof extra-adrenal
chromaffincellsareknownasparagangliomas.About85%
of pheochromocytomas arise from the adrenal medulla
and about 15% arise from extra-adrenal chromafin cells
[1]. Only few cases of pheochromocytoma in accessory
adrenal glands have been reported in literature. We present
a rare case of a patient with pheochromocytoma of an
accessory adrenal gland.
Case presentation
A 24-year-old Yoruba Nigerian female presented with
a four month history of hypertension and intermittent
bilateral frontal headache. There was an associated history
of photophobia, tinnitus, palpitation and diaphoresis. She
admitted having heat intolerance and insomnia. She had
lost weight significantly. There was no history of seizures
or loss of consciousness. Examination at presentation
revealed an anxious patient. There was no demonstrable
anterior neck swelling. Her pulse rate was 100 per minute,
regular and the blood pressure was 190/100 mmHg.
There were no significant findings in the abdomen. A
tentative diagnosis of pheochromocytoma was made. The
differential diagnosis was thyrotoxicosis. She was com-
menced on antihypertensive medications while she was
investigated. Results of investigations revealed a normal
thyroid function test, an elevated serum cholesterol level
(296 mg/dl) and a normal serum urea and electrolytes. An
abdominal ultrasound scan revealed a left suprarenal mass
displacing the left kidney postero-laterally, suggestive of a
left adrenal mass. A computerized tomography scan of the
abdomen revealed a rounded bi-lobed left suprarenal
Page 1 of 4
(page number not for citation purposes)mass of mixed density (Figure 1). The twenty-hour urine
metanephrine estimations were markedly elevated. A
diagnosis of pheochromocytoma was subsequently con-
firmed. She was commenced on Prazocin 0.5 mg p. o t.d.s
and Atenolol 100 mg b.i.d. Nifedipine 20 mg b.i.d was
subsequently added. The blood pressure was maintained
at 120/80 mmHg. She subsequently had surgery for
excision of the tumour using a transperitoneal approach.
There was a transient episode of intraoperative hypoten-
sion for which she was commenced on dopamine
infusion. Findings at surgery were
￿ A well encapsulated left suprarenal mass with dilated
veins draining into the left renal vein (Figure 2).
￿ A normal looking left adrenal gland superiorly adjacent
to the mass.
￿ A normal right adrenal gland.
The tumour was dissected out after ligating the blood
supply and the veins. A separate cresenteric shaped mass
was identified at the apex of the cavity this was also
removed.
ShewastransferredtotheIntensivecareunitformonitoring.
Her post-operative phase was uneventful. Anti-hypertensive
medications were discontinued and she was discharged
homeontheninthpost-operativedaywithabloodpressure
of 120/80 mmHg. She is being seen in the surgical out -
patient clinic. She has remained free of symptoms. The
histopathology report of the two resected specimens
revealed a cresenteric shaped normal intact adrenal gland
grossly and on histology. The mass (Figure 3) measured 8 ×
6 × 4.5 cm in size and weighed 100 gm. The surface was
lobulated with sparsely attached adipose tissue on its intact
capsular surface. Cut surface revealed a bi lobulated
yellowish brown surface. The histology showed a rim of
atrophic cortical adrenal tissue and deep to this rim were
nests and sheets of small to intermediated sized cells with
moderate pleomorphic nuclei with occasional bizarre ones
andwithmoderateamphophillictoeosinophilliccytoplasm
(Figure 4). The cells were arranged around delicate
vasculature. The chief cells in the tumour were strongly
positive for Neuron Specific Enolase, synaptophysin and
ChromograninA.Thesurroundingsustentacularnetworkof
cells stained positively for the S-100 protein. These findings
are suggestive of a pheochromocytoma in an accessory
adrenal gland.
Discussion
Accessory adrenal glands are seen in approximately half of
newborns but subsequently disappear later [2]. They
consist of cortical and glandular tissue and are predomi-
nantly in the abdomen and pelvis.
Accessory adrenal glands were initially documented by
both Jaffer and Soyer [3]. Graham in a subsequent study
Figure 1. Abdominal CT showing the left kidney and the over
lying mass.
Figure 2. Intra-operative photograph.
Figure 3. The gross image showing the bi-lobed mass.
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thirty-two percent of the autopsiesdone. Sixteen percent of
these glands contained both cortex and medulla [4]. The
origin of these glands is due to an embryological
developmental defect. The accessory adrenal gland sepa-
rates from the adrenal primodium during migration. The
accessory adrenal gland most often consists of cortical
tissue. The presence of the medulla is determined by the
time of separation from the primodium [3]. Very few cases
of pheochromocytoma arising from accessory adrenal
glands have been reported. A few reasons attributed to the
rarity of pheochromocytoma occurring in accessory
adrenal glands are the relatively low occurrence of
medullary tissue in these glands; a diminished cellular
basis for tumour transformation and the relative inactivity
of the medulla in the accessory adrenal glands. In addition
the tumour in the accessory adrenal gland tends to cause
cortical atrophy when it gets very large consequently
causing a misleading diagnosis of paraganglioma [5].
Tumour localization may be initially done with high
resolution ultrasonography. Other commonly used ima-
ging techniques include computerized tomography (CT)
and Magnetic resonance imaging (MRI) and scintigraphy
after the administration of 131 Metaiodobenzylguanidine
(MIBG). Although CTmay localizeabout 95%of tumours,
MRI is superior to CT in detecting these tumours especially
extra-adrenal tumours and metastatic pheochromo-
cytoma. MRI may be considered instead of CT in
pregnancy states and in patients allergic to contrast agents.
In some centers MIBG is used before CT for tumour
localization with recourse to MRI or CT for detailed
anatomical studies [6]. Recently, positron emission
tomography (PET) with 18Fluorodopamine or
18Fluorodeoxyglucose has been introduced for tumour
localization with superior results to MIBG [7]. However
abdominal MRI, MIBG and PET are not available in our
centre.
The clinical presentation of pheochromocytoma may
mimic other disease conditions such as hyperthyroidism
and panic disorders consequently causing delay in
diagnosis. Biochemical tests remain the hallmark of
diagnosis. This includes the determination of urinary
metabolites of catecholamine (nor-metanephrine and
metanephrine) and urinary vanillylmandelic acid [8].
Preoperative management involves the control of catecho-
lamine induced symptoms with the use of alpha and beta
blockers. Calcium channel blockers may also be consi-
dered. Intraoperative dangers to be aware of while
operating on patients with pheochromocytoma include
severe hypotension from a sudden reduction in catheco-
lamines due to tumour excision and hypoglycemia from
rebound hyperinsulinemia. There has been some con-
troversy on ectopic adrenal glands being responsible for
clinical manifestation of pheochromocytoma [9]. Our
experience with this case supports the fact that pheochro-
mocytoma can occur in an accessory adrenal gland though
this is rare. The clinical course and nature of phaechro-
mocytoma in functional accessory adrenal glands are not
well documented in literature. However, reports about
extra-adrenal paraganglioma have consistently shown that
they tend to run a more aggressive course, have a
likelihood of metastasis and a high incidence of persistent
and recurrent disease [10-14]. Metastasis is the only
indicator of malignancy in phaechromocytomas and
paragangliomas but the following factors are usually
associated with higher incidence of malignancy; tumour
weight greater than 80 g, tumour size greater than 5 cm,
extra-adrenal location, post operative persistent arterial
hypertension, relative young age, male gender and
immunohistochemical staining of MIB-1, a proliferative
index marker, greater than 3% [11-15].
Conclusion
This further demonstrates the rare possibility of the
development of pheochromocytoma outside the adrenal
gland.
Abbreviations
CT, computerized tomography; MIBG, Metaiodobenzyl-
guanidine; MRI, Magnetic resonance imaging; PET,
positron emission tomography.
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Figure 4. This shows the remnant atrophic adrenal cortical
tissue in the right aspect of the photomicrograph and the
tumour to the left (×200).
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